Spanish and Danes team up on oral probiotics

Spanish start-up AB-Biotics has signed a deal with Danish company CMS Dental to launch a range of oral probiotics in Denmark.

The scientific literature contains many examples of probiotics benefitting oral health, usually strains from the Lactobacillus ​family, although the European Union has not approved any such claims and has rejected many under its strict system.

“We have developed this project following our understanding of how probiotics should be selected and we have taken into account the opinion of key opinion leaders in the field of probiotics and dentistry.”​

Chief research officer in microbiology Jordi Cuñé Castellana, PhD, said the company was aware of the claims situation for its patent-protected formulation.

“We will not use any forbidden health claim for a food or food supplement. Nevertheless there are other possibilities [and other regulatory channels] to put the product in the market with or without claims. We are still dealing and discussing all the potential applications.”​

Under the deal, CMS Dental has the rights to market the formulation until 2022.

AB-Biotics said it would be parading AB-Dentis at various trade shows around the world this year beginning with International Dental Supply in Cologne, Germany this month.

The Pre- & Probiotics 2013 Online Event​The global pre- and probiotic markets are in good health, with an unparalleled number of studies backing the beneficial effects of the guy-friendly ingredients. Yet Europe’s 2012 ban of all pre- and probiotic claims – and even use of the terms ‘prebiotic’ and ‘probiotic’ – has led to big challenges in the global marketplace.

Taking place on March 26th, NutraIngredients presents Pre-and Probiotics 2013, an online conference to tackle the big issues in pre- and probiotics.